Directory
>
Glen Raffel
Glen Raffel
Vice President, Clinical Research and Development | Vor Bio
Boston, Massachusetts, United States
Glen Raffel
Summary
Glen Raffel is a distinguished leader in the field of clinical research and development with a robust background in biochemistry and hematology. Currently serving as the Vice President at Vor Biopharma, he has dedicated his career to advancing therapeutic approaches in hematologic malignancies and stem cell research. Glen's academic journey includes an M.D. Ph.D. from Tufts University, where he specialized in Molecular Microbiology. His professional tenure spans various reputable institutions including UMass Medical School and Beth Israel Deaconess Medical Center, where he held multiple faculty positions. Glen's research interests focus on hematopoietic stem cell function and leukemogenesis, contributing significantly to the understanding of blood disorders. He is also known for his technical writing and clinical trial oversight, enhancing the development of innovative therapies. With a blend of academic and industry experience, Glen is committed to improving patient outcomes through research and education. His leadership roles have positioned him as a key figure in the healthcare community, advocating for advancements in medical science.
Glen Raffel
Work Experience
Vice President, Clinical Research and Development at
Vor Bio
November 2020 - Present
Affiliate Associate Professor at
Umass Medical School
April 2018 - Present
Associate Professor at
UMass Memorial Medical Center
July 2016 - Present
Senior Medical Director at
Vor Bio
July 2020 - November 2020
Senior Medical Director at
Magenta Therapeutics
May 2018 - July 2020
Assistant Professor at
UMass Memorial Medical Center
January 2008 - July 2016
Assistant Professor at
Umass Medical School
January 2008 - July 2016
Instructor at
Beth Israel Deaconess Medical Center
January 2004 - January 2008
Instructor at
Harvard Medical School
January 2004 - January 2008
Hematology Consultant at
Beth Israel Deaconess Hospital-Needham
January 2006 - January 2008
Instructor at
Brigham and Women's Hospital
January 2004 - January 2008
Fellow at
Beth Israel Deaconess Medical Center
January 2000 - January 2004
Medical Resident at
Beth Israel Deaconess Medical Center
January 1998 - January 2000
Glen Raffel
Education
Tufts University School of Medicine, M.D. Ph.D.
January 1989 - January 1998
Bowdoin College, Bachelor Of Arts (B.A.)
January 1985 - January 1989
mcdonogh
January 1980 - January 1985
Frequently Asked Questions about Glen Raffel
What is Glen Raffel email address?
Glen Raffel's primary email address is *******@vorbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Glen Raffel work for?
Glen Raffel is a Vice President, Clinical Research and Development at Vor Bio, a company specializing in Biological products, except diagnostic.
Where Glen Raffel graduated from?
Glen Raffel holds a degree in Molecular Microbiology from Tufts University School of Medicine.
How can I directly contact Glen Raffel?
To contact Glen Raffel directly, you can use the email address *******@vorbio.com. Complete contact information is available upon registration with Muraena.
Who is Glen Raffel?
Glen Raffel is a distinguished leader in the field of clinical research and development with a robust background in biochemistry and hematology. Currently serving as the Vice President at Vor Biopharma, he has dedicated his career to advancing therapeutic approaches in hematologic malignancies and stem cell research. Glen's academic journey includes an M.D. Ph.D. from Tufts University, where he specialized in Molecular Microbiology. His professional tenure spans various reputable institutions including UMass Medical School and Beth Israel Deaconess Medical Center, where he held multiple faculty positions. Glen's research interests focus on hematopoietic stem cell function and leukemogenesis, contributing significantly to the understanding of blood disorders. He is also known for his technical writing and clinical trial oversight, enhancing the development of innovative therapies. With a blend of academic and industry experience, Glen is committed to improving patient outcomes through research and education. His leadership roles have positioned him as a key figure in the healthcare community, advocating for advancements in medical science.
Glen`s contact details
*******@vorbio.com
***********@umassmemorial.org
*******@vorbiopharma.com
***********@umassmed.edu
Colleagues
Vice President, Head of Gmp Operations
VP, Finance